Cleared Traditional

NMI VEIN GRAFT PERFUSION SET (K961181) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K961181 · Naltiac Medical, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1996
Decision
87d
Days
Class 2
Risk

K961181 is an FDA 510(k) clearance for the NMI VEIN GRAFT PERFUSION SET. Classified as Adaptor, Stopcock, Manifold, Fitting, Cardiopulmonary Bypass (product code DTL), Class II - Special Controls.

Submitted by Naltiac Medical, Inc. (Dallas, US). The FDA issued a Cleared decision on June 21, 1996 after a review of 87 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4290 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Naltiac Medical, Inc. devices

Submission Details

510(k) Number K961181 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 26, 1996
Decision Date June 21, 1996
Days to Decision 87 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
38d faster than avg
Panel avg: 125d · This submission: 87d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DTL Adaptor, Stopcock, Manifold, Fitting, Cardiopulmonary Bypass
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4290
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DTL Adaptor, Stopcock, Manifold, Fitting, Cardiopulmonary Bypass

All 26
Devices cleared under the same product code (DTL) and FDA review panel - the closest regulatory comparables to K961181.
HEMOSTASIS VALVE
K072556 · Merit Medical Systems, Inc. · Nov 2007
6248VAL ADJUSTABLE VALVE
K052459 · Medtronic Vascular · Jan 2006
MBA
K993057 · Merit Medical Systems, Inc. · Oct 1999
BRAUN MANIFOLD
K942391 · B.Braun Medical, Inc. · Jun 1995
CHECK VALVE (FITTING)
K933084 · Merit Medical Systems, Inc. · Mar 1994
STOPCOCK (ONE-PORT MANIFOLD)
K934123 · Merit Medical Systems, Inc. · Nov 1993